Switzerland· 69364002
Voranigo 40 mg, comprimés pelliculés
A vorasidenib product containing vorasidenibum, registered in Switzerland by Servier (Suisse) SA and dispensed under Swissmedic category A. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Vorasidenib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01XM04 (vorasidenib), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Vorasidenib · ATC L01XM04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- vorasidenibum
- Manufacturer
- Servier (Suisse) SA
- Country
- Switzerland (CH)
- ATC code
- L01XM04
- ATC class
- Vorasidenib
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vorasidenib in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesVORANIGOServier Pharmaceuticals LLC
- FranceVORANIGO 40 mg, comprimé pelliculéLES LABORATOIRES SERVIER
- NetherlandsVoranigo 40 mg filmomhulde tablettenLes Laboratoires Servier
- SpainVORANIGO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- PolandVoranigoLes Laboratoires Servier
- SwedenVoranigo 40 mg Filmdragerad tablettLes Laboratoires Servier
- NorwayVoranigoLes Laboratoires Servier
- United KingdomVoranigo 10mg tabletsServier Laboratories Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voranigo
- Liechtenstein · Voranigo
- Norway · Voranigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/827cec4a-c327-4538-99fc-888b3e430225 GET /v1/drugs/827cec4a-c327-4538-99fc-888b3e430225?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about vorasidenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.